Utilizing Index of Refraction Monitors in Biopharmaceutical Downstream Processing and Purification When the FDA published the 2003 document, “Pharmaceutical Current Good Manufacturing Practices (CGMPs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback